Recombinant KIR2DL2 (Lirilumab Biosimilar) 抗体
Research Grade
适用: 人
ELISA, WB
宿主: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all KIR2DL2 (Lirilumab Biosimilar) products
- KIR2DL2 (Lirilumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Human
- Expression System
- Mammalian cells
-
克隆类型
- 单克隆
-
标记
- This KIR2DL2 (Lirilumab Biosimilar) antibody is un-conjugated
- 应用范围
- ELISA, Western Blotting (WB)
- 原理
- Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade
- 产品特性
- Antibody Type: Human IgG1
- 纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
- 纯度
- > 85%
- 质量等级
- Research Grade
- 亚型
- IgG
-
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS buffer PH7.5
- 储存条件
- -80 °C
- 储存方法
- store at -80°C
-
- 抗原
- KIR2DL2 (Lirilumab Biosimilar)
- Abstract
- KIR2DL2 (Lirilumab Biosimilar) 产品
- 背景
- Lirilumab is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.
- CAS-编号
- 1000676-41-4
-
You are here:
